In 2006, Novartis fully commited US$755 million in corporate citizenship initiatives worldwide, specially specializing in bettering usage of medicines in the developing planet via its Access to Drugs tasks, including donations of medicines to people afflicted by leprosy, tuberculosis, and malaria; Glivec patient help programs; and relief to support main https://www.social-bookmarking.org/en/harnessing-cutting-edge-techniques-for-advanced-pharmaceutical-outcomes